# MOGAT3

## Overview
MOGAT3, or monoacylglycerol O-acyltransferase 3, is a gene that encodes an enzyme involved in lipid metabolism, specifically in the synthesis of triglycerides. The protein product of MOGAT3 is categorized as an acyltransferase, which plays a crucial role in the conversion of monoacylglycerol and fatty acyl-CoA into diacylglycerol, a key step in triglyceride formation. This enzymatic activity is essential for energy storage and lipid homeostasis within cells, occurring primarily in the endoplasmic reticulum (Cao2007Catalytic). MOGAT3 is expressed in various tissues, including the liver and small intestine, where it contributes to dietary fat absorption and triglyceride synthesis for chylomicron assembly (Hall2012Evidence; Brandt2016Biochemical). The enzyme's activity is regulated by substrate availability and cellular conditions, influencing its role in lipid storage and energy balance (Cao2007Catalytic).

## Function
MOGAT3, or monoacylglycerol O-acyltransferase 3, is an enzyme involved in lipid metabolism, specifically in the synthesis of triglycerides. It catalyzes the conversion of monoacylglycerol and fatty acyl-CoA into diacylglycerol, a precursor for triglyceride formation. This process occurs in the endoplasmic reticulum and plays a role in energy storage and lipid homeostasis in cells (Cao2007Catalytic).

MOGAT3 exhibits both monoacylglycerol acyltransferase (MGAT) and diacylglycerol acyltransferase (DGAT) activities, indicating its dual role in lipid synthesis pathways. It is more closely related to DGAT2 than to other MGAT enzymes, suggesting a significant role in triacylglycerol (TAG) synthesis (Cao2007Catalytic; Brandt2016Biochemical). In human liver cells, MOGAT3 expression correlates with MGAT activity, and its overexpression leads to increased triacylglycerol accumulation, highlighting its involvement in lipid metabolism (Hall2012Evidence).

MOGAT3 is expressed in both the liver and small intestine, with its activity being more prominent in the intestine, where it contributes to dietary fat absorption and triglyceride synthesis for chylomicron assembly (Hall2012Evidence; Brandt2016Biochemical). The enzyme's activity is regulated by factors such as substrate availability and cellular conditions, which influence its role in lipid storage and energy balance (Cao2007Catalytic).

## Clinical Significance
Alterations in the expression of the MOGAT3 gene have been implicated in several metabolic disorders. MOGAT3 is involved in the synthesis of triacylglycerol (TAG), and its overexpression is associated with nonalcoholic fatty liver disease (NAFLD) and obesity-related insulin resistance. In obese individuals, hepatic expression of MOGAT3 is correlated with increased MGAT activity, and its expression is upregulated in NAFLD. Weight loss following gastric bypass surgery has been shown to reduce MOGAT3 expression, suggesting its role in obesity-related conditions (Huard2015Discovery).

In the context of prostate cancer, MOGAT3's role in glycerolipid metabolism is highlighted, particularly in periprostatic adipose tissue (PPAT) of patients with excess adiposity. Although there is no direct evidence linking MOGAT3 expression to prostate cancer, its methylation in PPAT may influence lipid metabolism in response to obesity (Cheng2018Epigenomewide).

In X-linked adrenoleukodystrophy (X-ALD), MOGAT3 expression is higher in the adrenomyeloneuropathy (AMN) phenotype compared to childhood cerebral adrenoleukodystrophy (CCALD), suggesting a more active triglyceride anabolic pathway in AMN (Lee2019Integrative). These findings indicate that MOGAT3 may be a potential target for therapeutic interventions in metabolic disorders.


## References


[1. (Cao2007Catalytic) Jingsong Cao, Long Cheng, and Yuguang Shi. Catalytic properties of mgat3, a putative triacylgycerol synthase. Journal of Lipid Research, 48(3):583–591, March 2007. URL: http://dx.doi.org/10.1194/jlr.m600331-jlr200, doi:10.1194/jlr.m600331-jlr200. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m600331-jlr200)

[2. (Lee2019Integrative) Dong-Kyu Lee, Nguyen Phuoc Long, Juwon Jung, Tae Joon Kim, Euiyeon Na, Yun Pyo Kang, Sung Won Kwon, and Jiho Jang. Integrative lipidomic and transcriptomic analysis of x-linked adrenoleukodystrophy reveals distinct lipidome signatures between adrenomyeloneuropathy and childhood cerebral adrenoleukodystrophy. Biochemical and Biophysical Research Communications, 508(2):563–569, January 2019. URL: http://dx.doi.org/10.1016/j.bbrc.2018.11.123, doi:10.1016/j.bbrc.2018.11.123. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2018.11.123)

[3. (Hall2012Evidence) Angela M. Hall, Kou Kou, Zhouji Chen, Terri A. Pietka, Mrudula Kumar, Kevin M. Korenblat, Kyuha Lee, Kay Ahn, Elisa Fabbrini, Samuel Klein, Bryan Goodwin, and Brian N. Finck. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. Journal of Lipid Research, 53(5):990–999, May 2012. URL: http://dx.doi.org/10.1194/jlr.p025536, doi:10.1194/jlr.p025536. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.p025536)

[4. (Brandt2016Biochemical) Curtis Brandt, Pamela J. McFie, and Scot J. Stone. Biochemical characterization of human acyl coenzyme a: 2-monoacylglycerol acyltransferase-3 (mgat3). Biochemical and Biophysical Research Communications, 475(3):264–270, July 2016. URL: http://dx.doi.org/10.1016/j.bbrc.2016.05.071, doi:10.1016/j.bbrc.2016.05.071. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2016.05.071)

[5. (Huard2015Discovery) Kim Huard, Allyn T. Londregan, Gregory Tesz, Kevin B. Bahnck, Thomas V. Magee, David Hepworth, Jana Polivkova, Steven B. Coffey, Brandon A. Pabst, James R. Gosset, Anu Nigam, Kou Kou, Hao Sun, Kyuha Lee, Michael Herr, Markus Boehm, Philip A. Carpino, Bryan Goodwin, Christian Perreault, Qifang Li, Csilla C. Jorgensen, George T. Tkalcevic, Timothy A. Subashi, and Kay Ahn. Discovery of selective small molecule inhibitors of monoacylglycerol acyltransferase 3. Journal of Medicinal Chemistry, 58(18):7164–7172, September 2015. URL: http://dx.doi.org/10.1021/acs.jmedchem.5b01008, doi:10.1021/acs.jmedchem.5b01008. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/acs.jmedchem.5b01008)

[6. (Cheng2018Epigenomewide) Yan Cheng, Cátia Monteiro, Andreia Matos, Jiaying You, Avelino Fraga, Carina Pereira, Victoria Catalán, Amaia Rodríguez, Javier Gómez-Ambrosi, Gema Frühbeck, Ricardo Ribeiro, and Pingzhao Hu. Epigenome-wide dna methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity—a pilot study. Clinical Epigenetics, April 2018. URL: http://dx.doi.org/10.1186/s13148-018-0490-3, doi:10.1186/s13148-018-0490-3. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-018-0490-3)